Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study.
Increased residual platelet reactivity remains a burden for coronary artery disease (CAD) patients who received a coronary stent and do not respond sufficiently to treatment with acetylsalicylic acid and clopidogrel. We hypothesized that serotonin antagonism reduces high on-treatment platelet reacti...
Guardado en:
Autores principales: | Daniel Duerschmied, Ingo Ahrens, Maximilian Mauler, Christoph Brandt, Stefanie Weidner, Christoph Bode, Martin Moser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/59bf5da1feeb4e0da8ab90193bfb2df1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
por: Nikita Lomakin, et al.
Publicado: (2019) -
Antithrombotic Therapy after Venous Stent Placement
por: Nicholas Xiao, et al.
Publicado: (2020) -
Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
por: Rory Marples, MBBS, et al.
Publicado: (2022) -
Impulsivity, gender, and the platelet serotonin transporter in healthy subjects
por: Donatella Marazziti, et al.
Publicado: (2009) -
Platelet serotonin level predicts survival in amyotrophic lateral sclerosis.
por: Luc Dupuis, et al.
Publicado: (2010)